Novel role for epalrestat: protecting against NLRP3 inflammasome-driven NASH by targeting aldose reductase

BACKGROUND: Nonalcoholic steatohepatitis (NASH) is a progressive and inflammatory subtype of nonalcoholic fatty liver disease (NAFLD) characterized by hepatocellular injury, inflammation, and fibrosis in various stages. More than 20% of patients with NASH will progress to cirrhosis. Currently, there...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Wei, Xu, Guang, Gao, Yuan, Zhao, Jun, Liu, Tingting, Zhao, Jia, Yang, Huijie, Wei, Ziying, Li, Hui, Xu, An-Long, Bai, Zhaofang, Xiao, Xiaohe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560438/
https://www.ncbi.nlm.nih.gov/pubmed/37805545
http://dx.doi.org/10.1186/s12967-023-04380-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560438/
https://www.ncbi.nlm.nih.gov/pubmed/37805545
http://dx.doi.org/10.1186/s12967-023-04380-4

Ejemplares similares